Maxillofacial Implants Market Size, Share and Analysis by Product (Screws, Mesh, Plates), By Material (Titanium, Polymers), By End-user (Hospitals, Ambulatory surgical centers, Specialty clinics) and Regional Forecast, 2025-2032

In March 2019, Medtronic launched Grafton demineralized bone matrix (DBM) a bone grafting product in Japan Market. Maxillofacial surgeries are performed to treat diseases associated with mouth, jaws, face, and neck. Moreover, these surgeries are performed for the restructuring of facial parts.

The maxillofacial implant offers replacements and restoration of dysfunctional or missing anatomical structures to improve the function of defective facial parts. Certain factors such as facial injuries, fractures, soft tissue injuries, and facial tumors, amongst others, are prominently responsible for abnormal facial conditions.

To gain extensive insights into the market, Download for Customization

The emerging use of certain software such as CAD (computer-aided design and drafting)/ CAM (Computer-aided manufacturing) for designing and development of maxillofacial implants offers greater precision, which leads to enhanced treatment outcomes.

Global Maxillofacial Implants market growth is being driven by the increasing number of maxillofacial surgeries across the globe. Moreover, the growing emphasis on better aesthetic appearance is projected to boost the adoption of maxillofacial surgeries during the forecast period. According to the American Society of Craniofacial Surgeons, an estimated 1 in 1000 babies inborn with cleft palate each year in the U.S., which is anticipated to boost the demand for maxillofacial implants.

On the flip side, the certain factors such as lack of healthcare infrastructure and higher costs associated with maxillofacial surgeries in emerging nations are anticipated to reduce the adoption of maxillofacial surgeries, resulting into restraining the growth of the global maxillofacial implants market.

Key Players Covered

Some of the major companies covered in the global maxillofacial implants market report are Rebstock Instruments GmbH, OsteoMed, Materialise, Johnson & Johnson Services, Inc Stryker, Medtronic, Integra LifeSciences, DePuy Synthes, Integer Holdings Corporation, KLS Martin Group, Medartis, Zimmer Biomet, B. Braun Melsungen AG, MATRIX SURGICAL USA, CONMED Corporation, Calavera Surgical Design and others.

SEGMENTATION

As per the current maxillofacial implants market trends, the titanium segment among the material is anticipated to hold a considerable share of the global maxillofacial implants market during the forecast period. Certain benefits offered by titanium such as higher strength and resistant to degradation is expected to boost the adoption of titanium by 2026.

Key Insights

• Number of maxillofacial procedures for key countries (2018)
• The regulatory scenario for key countries
• Reimbursement scenario for key countries
• Recent industry developments such as partnerships, mergers, and acquisitions
• Key industry trends 

Regional Analysis

The global maxillofacial implants market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global maxillofacial implants market over the forecast period owing to the increasing number of maxillofacial surgeries per year. Moreover, higher per capita healthcare expenditure and developed healthcare infrastructure are equally projected to drive the growth of the market in North America by 2026. The maxillofacial market in Europe is expected to expand in the forecast period owing to new product launch and increasing incidence of facial injuries. The Asia Pacific and Middle East & Africa hold huge potential for growth of the global maxillofacial implants owing to the growing awareness regarding external and internal implants, increased healthcare investment, and active government support.

Maxillofacial Implants Industry Developments

• In March 2019, Evonik launched new radiopaque material, PEEK, which can be utilized for implant technology. The newly launched material can be utilized in maxillofacial implants, also, it offers improved biocompatibility and bio-stability.
• In December 2016, Micro Interventional Devices, Inc. announced that it accomplished the first implantation of the company’s MIA implant in the STTAR clinical trial of the device indicated for tricuspid valve repair.